» Auto updated continuously

Display limited to 'Reasanz' in document titles and meta descriptions. Display In Whole Documents or use the calendar above to adjust the date setting.

 2014-03-27 20:31 


FDA Advisory Panel Recommends Against Approval Of Novartis Heart Failure Drug... +

(Updated with a statement from Novartis) The FDA's Cardiovascular and Renal Drugs Advisory Committee voted unanimously  (11-0) against approval of the biologics license application (BLA) for serelaxin (proposed trade name Reasanz). The novel drug from N...

 2014-01-24 17:49 


CHMP: No to Serelaxin (Reasanz), Yes to Riociguat (Adempas)... +

The EMA's CHMP made two decisions this week on cardio-related drugs, saying yes to riociguat for the treatment of pulmonary hypertension, but no to serelaxin for the treatment of acute heart failure. International Approvals...

  • Need an account?